FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
India has a pivotal role in eliminating TB
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Time to combine innovation, access and technology to deliver positive patient outcomes
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Subscribe To Our Newsletter & Stay Updated
